FULVESTRANT is a Intramuscular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Xiromed, Llc. The primary component is Fulvestrant.
Product ID | 70700-284_6c925fcb-edcf-fdff-d723-603f4227821b |
NDC | 70700-284 |
Product Type | Human Prescription Drug |
Proprietary Name | FULVESTRANT |
Generic Name | Fulvestrant |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2021-08-19 |
Marketing Category | ANDA / |
Application Number | ANDA213553 |
Labeler Name | Xiromed, LLC |
Substance Name | FULVESTRANT |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2021-08-19 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9022 | Fulvestrant | Fulvestrant |
0310-7720 | Fulvestrant | Fulvestrant |
0591-5019 | Fulvestrant | Fulvestrant |
0781-3079 | Fulvestrant | Fulvestrant |
0781-3492 | Fulvestrant | Fulvestrant |
16714-070 | FULVESTRANT | fulvestrant |
16714-118 | Fulvestrant | Fulvestrant |
16729-436 | FULVESTRANT | Fulvestrant |
25021-462 | fulvestrant | fulvestrant |
43598-262 | Fulvestrant | Fulvestrant |
70121-1463 | Fulvestrant | Fulvestrant |
63323-715 | Fulvestrant | Fulvestrant |
67457-311 | Fulvestrant | Fulvestrant |
68462-317 | Fulvestrant | Fulvestrant |
70534-002 | fulvestrant | fulvestrant |
68001-424 | fulvestrant | fulvestrant |
68842-301 | Fulvestrant | Fulvestrant |
70860-211 | Fulvestrant | Fulvestrant |
71288-555 | Fulvestrant | Fulvestrant |
71731-6121 | Fulvestrant | Fulvestrant |
72603-105 | Fulvestrant | Fulvestrant |
0310-0720 | FASLODEX | Fulvestrant |